Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about AGERPROTEIN: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
AGER, commonly known as RAGE (Receptor for Advanced Glycation End Products), is a pattern recognition receptor that plays a central role in linking metabolic stress, oxidative damage, and neuroinflammation in neurodegenerative diseases[@schmidt2000].
No AI portrait yet
| Gene Symbol | AGERPROTEIN |
| Full Name | AGER/RAGE |
| Chromosome | 6p21.3 |
| Protein Type | Protein |
| Target Class | Protein |
| Function | is a pattern recognition receptor that plays a central role in linking metabolic stress, oxidative damage, and neuroinflammation in neurodegenerative diseases[@schmidt2000]. |
| Mechanism of Action | Prioritized from 1 SciDEX hypotheses, including: Blocking AGE-RAGE Signaling in Enteric Glia to Prevent Neuroinflammatory Cascade |
| Primary Expression | various cell types within the central nervous system, including neurons, astrocytes, microglia, and vascular endothelial cells, where it mediates resp |
| Druggability | Undruggable (0.23) |
| UniProt ID | Search UniProt |
| GeneCards | AGERPROTEIN |
| Human Protein Atlas | AGERPROTEIN |
| Associated Diseases | AD, ALI, als, Alzheimer's disease |
| Known Drugs/Compounds | CHEMBL2179074, CHEMBL2205553, CHEMBL2205552, CHEMBL2205550, CHEMBL2205549, CHEMBL2205572 |
| Interactions | EGFR, HER2, HLA, HSPA1A, HSPA1B, NCOA4 |
| SciDEX Target | View Target Profile |
| SciDEX Hypotheses | Blocking AGE-RAGE Signaling in Enteric Glia to Pre |
| KG Connections | 144 knowledge graph edges |
| Databases | GeneCardsNCBI GeneHPASTRING |
Knowledge base pages for this entity
graph TD
AGERPROTEIN["AGERPROTEIN"]
neurodegeneration["neurodegeneration"]
AGERPROTEIN -->|"implicated_in"| neurodegeneration
style AGERPROTEIN fill:#4a1a6b,stroke:#4fc3f7,stroke-width:2px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| No outgoing edges | |||
| Source | Relation | Type | Str |
|---|---|---|---|
| No incoming edges | |||
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning AGERPROTEIN in their description or question text
No additional research found